Skip Navigation
Search Menu

HopkinsMedicine

2016-2019 ArchivesBack to Publications

Contents+

Winter 2018

 

Circling the Dome

Sowers at the Helm

On February 1, Kevin W. Sowers, a distinguished clinician, educator and academic health care leader, stepped into his new role as president of Johns Hopkins Health System and executive vice president of Johns Hopkins Medicine.

Read More
Kevin Sowers

Boardroom Dedicated to Honor Mary Elizabeth Garrett

The serene visage of Mary Elizabeth Garrett now looks down from the walls of the school of medicine trustees’ boardroom, which in January was named to honor the woman who made by far the largest donation to an ambitious $500,000 fundraising campaign that enabled the Johns Hopkins University School of Medicine to open in 1893.

Read More
Mary Elizabeth Garrett portrait

Health Apps at Your Fingertip

A new central listing of mobile clinical apps from Johns Hopkins highlights more than 45 apps for health care providers, students, patients and caregivers.

Read More
app icons illustrated

“Dr. Laiho’s research may prove to be a transformational cancer treatment. We’re excited that Bluefield has provided her an opportunity to accelerate its development and commercialization.”

William Nelson, director of the Johns Hopkins Sydney Kimmel Cancer Center, speaking of the first project to be accepted for funding by Bluefield Innovations, a collaboration between Johns Hopkins University and Deerfield Management to catalyze early stage therapeutic development. The project, which originated in the lab of oncology researcher Marikki Laiho, illustrates how cancer cells disproportionately rely on the RNA polymerase I cellular pathway when compared to normal cells. Bluefield, which launched in November, will provide scientific, financial and operational support to Laiho’s research, enabling her team to identify the clinical lead molecule and move toward human clinical trials. Ultimately, this support could lead to the development of a first-in-class small molecule drug.